PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION

PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION

Show other versions (1)

<p>For prevention of thromboembolic events in patients with non-valvular atrial fibrillation (NVAF) the following types of antithrombotic therapy are used: anticoagulant therapy with vitamin K antagonists (warfarin), antiplatelet therapy (acetylsalicylic acid) and novel oral anticoagulants suc...

Full description

Bibliographic Details
Main Author: A. V. Rudakova
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
фибрилляция предсердий
новые пероральные антикоагулянты
анализ затраты-эффективность
апиксабан
ривароксабан
дабигатран
варфарин
ацетилсалициловая кислота
Online Access:http://www.rpcardio.ru/jour/article/view/61

Internet

http://www.rpcardio.ru/jour/article/view/61

Similar Items